NLRP3 and amyotrophic lateral sclerosis: This result could support the idea that NLRP3 has a favorable function by acting as a transcription factor of IL-4, since it is in accordance with the previously mentioned gene therapy study with this cytokine performed on our animal model in which positive effects were observed mainly in the early slowly progressive phase of ALS [51].